Paul A. Luciw

17.4k citations
200 papers · 14.3k indexed · 8 hit papers · h-index 63
Topics
HIV Research and Treatment (127 papers)HIV/AIDS drug development and treatment (46 papers)Herpesvirus Infections and Treatments (43 papers)

In The Last Decade

Paul A. Luciw

199 papers receiving 13.8k citations

Hit Papers

Anti-termination of transcription within the long termina...198020261995201019871988198619851988250500750

Peers

Paul A. Luciw
Comparison fields: 5 of 144
  • Virology 8.1k
  • Molecular Biology 4.5k
  • Epidemiology 4.4k
  • Infectious Diseases 4.2k
  • Immunology 4.0k
Replace George N. Pavlakis with:
George N. Pavlakis United States
Scott Koenig United States
Dani P. Bolognesi United States
Malcolm A. Martin United States
Yoshio Koyanagi Japan
Paul R. Clapham United Kingdom
Paul D. Bieniasz United States
Christopher C. Broder United States
Michael H. Malim United Kingdom
Janice E. Clements United States
Paul A. Luciw relative to George N. Pavlakis United States George N. Pavlakis's profile →
Citations per field
00.5×1.5×1.9×
George N. Pavlakis · 1×
Citations per year

Countries citing papers authored by Paul A. Luciw

Since Specialization
Citations

This map shows the geographic impact of Paul A. Luciw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul A. Luciw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul A. Luciw more than expected).

Fields of papers citing papers by Paul A. Luciw

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul A. Luciw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul A. Luciw. The network helps show where Paul A. Luciw may publish in the future.

Co-authorship network of co-authors of Paul A. Luciw

This figure shows the co-authorship network connecting the top 25 collaborators of Paul A. Luciw. A scholar is included among the top collaborators of Paul A. Luciw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul A. Luciw. Paul A. Luciw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 15
3
Cloning, expression and genetic immunization studies of Mycobacterium tuberculosis gene esat6
0
4 57
5
Expression and Purification of Mycobacterium tuberculosis Antigens for Use in Immunoassays for Serodetection of M. tuberculosis Infection in TB Patients
1
6 31
7 5
8 7
9 13
10 135
11 51
12 105
13 20
14 52
15 83
16 5
17 27
18 8
19 114
20 9

About Paul A. Luciw

Paul A. Luciw is a scholar working on Virology, Infectious Diseases and Epidemiology, having authored 200 papers that have together received 14.3k indexed citations. Recurring topics across this work include HIV Research and Treatment (127 papers), HIV/AIDS drug development and treatment (46 papers) and Herpesvirus Infections and Treatments (43 papers). The work is most often cited by research in Virology (8.1k citations), Infectious Diseases (4.2k citations) and Immunology (4.0k citations). Paul A. Luciw has collaborated with scholars based in United States, France and Pakistan. Frequent co-authors include B. Matija Peterlin, Jay A. Levy, Harold Varmus, Cecilia Cheng‐Mayer, Michael D. Power, Katherine A. Jones, Philip J. Barr, B. Matija Peterlin, Shaw-Yi Kao and Andrew F. Calman. Their work appears in journals such as Nature, Science and Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026